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ABSTRACT 
The present work involved the development of a poly(lactic-co-glycolic acid) (PLGA)-coated, 
porous 58S bioactive glass-ceramic scaffold for the bone-forming layer of a future bilayered 
scaffold for osteochondral tissue engineering.  Scanning electron microscopy (SEM), 
mechanical testing and preliminary cell culture investigations were performed to determine the 
suitability of the scaffold for the subchondral bone tissue engineering application.  The 
bioactive-glass ceramic scaffolds possessed excellent pore interconnectivity. Mechanical testing 
of the PLGA-coated bioactive glass-ceramic scaffolds demonstrated a compressive strength of 
0.25±0.05 MPa.  The capacity of the bioactive glass-ceramic scaffold to proliferate human bone 
marrow stromal cells (BMSCs) was also assessed through in vitro culturing.  SEM morphology 
investigations revealed that the BMSCs had a relatively high affinity for the PLGA-coated 
bioactive glass-ceramic scaffold and significant attachment and proliferation towards 
confluence occurred over a 21 day period.   
 
 
INTRODUCTION 
 Osteochondral tissue engineering, a hybrid of bone and cartilage regeneration has emerged as a 
tangible alternative for promoting superior cartilage integration as well as a treatment for 
osteochondral defects, which pertain to joint damage that extends the articular cartilage and 
penetrates the underlying subchondral bone [1-3]. Bilayered scaffolds can be used to encourage 
simultaneous bone and cartilage growth to form integrated repair tissue. The incorporation of 
bilayered scaffolds assists in the establishment of tissue specific biological environments for 
each respective layer via variations in the physiochemical properties of the comprising scaffold 
layers. 
       
      Scaffolds for bone tissue engineering have been produced through a surfactant foaming and 
casting process incorporating sol-gel derived bioactive glass [4], as well as porous dry powder 
pressing and polymer replication using melt-derived 45S5 Bioglass® [5,6].  Scaffolds produced 
by polymer replication have been shown to possess structural properties similar to those of 
trabecular bone [7]. Sol-gel derived 58S bioactive glass has been shown to facilitate a faster rate 
of ionic dissolution and associated hydroxyl-carbonated apatite (HCA) layer formation 
compared to that of the melt-derived 45S5 Bioglass® alternative [8]. Thus, it was thought that 
58S sol-gel bioactive glass-ceramic scaffolds when toughened by a biodegradable polymer (e.g. 
PLGA) would possess the physiochemical properties required to promote the bone formation for 
the repair of the subchondral bone of an osteochondral defect. 
 
      The work reported in this paper was about the scaffolds only suitable for the subchondral bone 
tissue engineering. The ultimate aim of our research is the formation of an integrated bilayered 
scaffold consisting of the current bioactive glass-ceramic scaffold layer and an additional 
biopolymer scaffold layer for entire osteochondral (i.e. bone-cartilage) tissue engineering. The 
bilayered scaffolds may be used to additionally deliver growth factors to promote cartilage 
growth, while ensuring improved engineered tissue integration via bone growth into the 
subchondral scaffold layer at the osteochondral defect site.   
 
 
MATERIALS AND METHODS 
 
Scaffold fabrication 
58S bioactive glass, a ternary system of composition SiO2 (58 wt%)-CaO (33 wt%)-P2O5 (9 
wt%), was produced using reagent grade chemicals: tetraethoxysilane (TEOS, Si(OC2H5)4; 
131903, Aldrich); triethylphosphate (TEP, PO(OC2H5)3; 538728, Aldrich); and calcium nitrate 
(CN, Ca(NO3)2.4H2O; 237124, Sigma-Aldrich) by a sol-gel method as described elsewhere 
[9,10].  Briefly, an HCl-water solution of pH 0.5 was prepared by combining a measured 
quantity of 1N HCl to a beaker of demineralized water.  A ratio of mols of water to mols of 
TEOS of 8 was used for the present study.  TEOS was added to the acid-water solution and 
magnetically stirred for thirty minutes to facilitate partial hydrolysis.  TEP was then 
subsequently combined before being stirred for an additional twenty minutes.  Finally, a suitable 
quantity of CN was progressively added to the solution and allowed to mix for one hour to 
permit further hydrolysis and complete dissolution of reagents.  The resultant solution was then 
covered and sealed with aluminum foil and allowed to age in a temperature control chamber 
(Votsch VCL 4006) at 60°C and 55% relative humidity for 54 hours.  Following aging the 
supernatant was removed and the sol gel was allowed to dry under near equilibrium drying 
conditions in the same chamber up to a temperature of 130°C at 95 % relative humidity for 72 
hours.  A final stabilization (calcination treatment) phase was performed in a furnace up to 
700°C.  The resultant bioactive glass particles were ground and sieved and then ball milled for 
24 hours to produce fine bioglass powder.   
 
Porous bioactive glass-ceramic scaffolds were produced using the polymer replication technique 
as articulated previously [11].  Specifically, polyurethane (PU) foams were cut into a variety of 
sizes and immersed in a dilute sodium hydroxide (NaOH) solution before being rinsed clean 
with water. The PU foams were dried and stored in a vacuum desiccator until use.  Bioactive 
glass slurry was prepared through the measured addition of 40 grams of bioactive glass to a 
beaker of demineralised water to form a 45% w/v mixture.  The mixture was stirred using a 
magnetic stirrer for one hour.  Aqueous solutions of 25 wt% sodium polymethacrylic acid and 
10 wt% polyvinyl alcohol (PVA) were used as a dispersant and a binder respectively and added 
to the slurry mixture at a concentration of 1 wt% on the basis of bioactive glass weight.  The 
resultant solution was stirred for periods of thirty minutes and one hour following the addition 
of the dispersant and the binder.  A porous green construct was produced by immersing the PU 
foams into the bioactive glass slurry ensuring complete penetration of slurry throughout the 
entire foam structure.  The foams were manually retrieved and the excess slurry was squeezed 
out by hand.  A compressed air gun was used to eliminate any pore blockages ensuring a 
relatively homogenous coating on the struts of the foam.  The green ceramic foams were 
allowed to dry on a smooth flat surface for twenty-four hours before being sintered.  A two 
stage heat treatment regime was used to sinter the scaffolds.  A temperature of 600°C held 
constant for one hour was used to burn off the sacrificial polymer template, with a subsequent 
sintering period of one hour at 1000°C used to promote densification of the scaffold struts.  The 
rate of temperature increase and decrease during sintering was 2°C/min and 5°C/min 
respectively. The scaffolds were finally coated with a thin layer of poly(lactic-co-glycolic acid) 
(PLGA). For coating with the PLGA, PLGA pellets (Sigma–Aldrich; PLA:PGA = 75:25; mol. 
wt = 90,000–126,000) were dissolved in dimethyl carbonate (DMC, ≥ 99%, 517127, Sigma 
Aldrich) at a ratio of 1:5 wt/vol. The polymer-solvent solution was sonicated for 15 minutes just 
prior to use. Then the bioactive glass-ceramic scaffolds were immersed into the polymer 
solution, drained by taking out of the scaffolds and then centrifuged at 1000 rpm for 1 minute to 
remove the excess polymer solution. The coating action was repeated to ensure a homogenous 
coating of the struts throughout the entire scaffolds.  The scaffolds were then allowed to dry for 
12 hours in a fume hood and then for 24 hours in a vacuum desiccator to assist solvent 
evaporation.   
 
Scaffold characterisation 
 Sintered and PLGA-coated bioactive glass-ceramic scaffolds were examined by SEM to assess 
important macro- and micro- structural characteristics.  Each specimen was mounted onto a 
separate aluminium stub using carbon tape and coated with gold film on a sputter coater 
(BioRad SC500) in an argon atmosphere.  The individual samples were then analyzed using a 
scanning electron microscope (FEI QUANTA 200) and viewed under an acceleration operation 
voltage at 20 kV. 
 
The total porosity (P) of the bioactive glass-ceramic scaffold (as sintered) as well as the scaffold 
coated with PLGA was determined using the relationship between the bulk density (ρB) and the 
theoretical density of the scaffold: 
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where, ρB1 is for the as sintered scaffold, ρBG is the theoretical density of the bioactive glass-
ceramic, ρB2 is the bulk density of the scaffold coated PLGA, and ρPLGA is the theoretical density 
of PLGA. The theoretical density of the bioactive glass-ceramic sintered at 1000 °C was 
estimated to be approximately 3.125 g/cm2, as obtained through aprevious study while for 
PLGA a theoretical density value of 1.25 g/cm2 was used.  The bulk densities were calculated 
from measurements of the weights and volumes of individual scaffolds.   
 
 The compressive strengths of the PLGA-coated bioactive glass-ceramic scaffolds were 
measured individually using a Hounsfield testing machine with a load cell of 500 N.  
Cylindrical samples with a diameter of 6 mm were prepared for all compressive tests with a 
height of 20mm being used for the bioactive glass-ceramic scaffolds.  Prior to testing, the distal 
ends of the bioactive glass-ceramic were immersed and fixed in a liquid paraffin wax up to 5 
mm, which was used to ensure uniform loading of the scaffold cross section during testing and 
prevent any shearing force being applied at the extremities.  A loading rate of 0.5 mm/min was 
used for all compressive testing with 5 specimens from each category being assessed.  During 
testing, the compressive load was applied until densification of the bioceramic struts and 
compaction of microspheres was observed.   
 
In vitro evaluation by cell culture 
 PLGA coated-bioactive glass-ceramic scaffolds were used for in vitro evaluation by cell culture.  
For cell morphology studies, scaffolds with dimensions 4 mm x 4 mm x 4 mm were placed into 
individual 96 well plates. All samples were sterilised in 70% ethanol for thirty minutes with 
samples subsequently rinsed twice with potassium phosphate buffer solution (PBS) before being 
allowed to dry in a fume hood overnight.  Before cell seeding, the scaffolds were incubated in 
standard Dulbecco’s modified Eagle medium (DMEM) culture medium for a 48 hour period.   
 
 BMSCs were obtained by the method developed early [12]. Before seeding of the BMSCs, the 
incubating medium was removed from the scaffold well plates through aspiration.  
Approximately 10 μL of DMEM standard medium was directed onto the scaffold as a means of 
wetting the scaffold to prevent drying out of cells following incubation as well as to provide 
nutrients to these cells during initial seeding. Then 1x104 cells were used for scaffold 
morphology investigations. Following seeding, the cells were allowed to adhere for 3 to 4 hours 
before being topped up with standard medium.  1 mL was added to the 96 well plates used for 
morphology investigations.  The scaffolds were then incubated at 37°C in a humidified 
atmosphere containing 5 % (v/v) carbon dioxide for the designated time periods with the 
medium changed every 3 days during culture.   
 
 Cell morphology and attachment onto the bioactive glass-ceramic scaffold was observed using 
SEM.  Scaffolds were cultured for 3 days, 5 days and 21 days in standard culture medium.  
Following culture, the medium was removed through aspiration and scaffolds were rinsed with 
PBS before being fixed with a 3% glutaraldehyde solution.  The fixed scaffolds were stored at 
4 °C until further processing.  Before SEM observation, the scaffold samples were prepared 
using a standardized process.  The preparation procedure involved an initial buffer wash using 
0.1 M cacodylate buffer followed by a dehydration process facilitated through a series of 
increasing grade concentration ethanol solutions with a repetition at each stage.  The 
dehydration process was completed through a repeat incubation in 100% amyl acetate.  Final 
drying was performed using a supercritical point dryer of carbon dioxide (Denton Vacuum 
critical point dryer).  The scaffolds were then mounted on aluminum stubs and subsequently 
coated with gold using the same sputter coater as before and stored in a desiccator until SEM 
viewing.  For cell morphology assessment a voltage of 10 kV was used.   
 
 
RESULTS AND DISCUSSION 
 
Scaffold structure 
The porous 58S bioactive glass-ceramic scaffold, produced by polymer replication maintained 
the comprehensive pore interconnectivity of its PU foam template.  The total porosity of the 
bioactive glass ceramic scaffold without PLGA coating was calculated to be approximately 
88.21 ± 0.846 %.  This porosity value accounted for the macro- and micro- porosity that 
presented in the as sintered samples and was consistent with previous studies which developed a 
hydroxyapatite/tri-calcium phosphate scaffold using the same PU foam template [11].  The 
addition of the PLGA coating did not appear to significantly modify the macroporous structure 
of the scaffold.  In contrast, the micropores apparent on the individual struts of the as sintered 
scaffold were infiltrated with PLGA following coating, which probably accounted for the 
approximate 2% reduction in overall porosity.  The polymer coating also appeared to repair 
crack-like defects that presented in the as sintered scaffold due to processing and handling as 
well as any microvoids that were created as a result of the burning-off of the original PU 
template during scaffold sintering. The open macropore size distribution of the PLGA coated 
bioactive glass-ceramic scaffold, characterized from SEM micrographs (Figure 1), was within 
the range of approximately 220-500 μm, with the thickness of scaffold struts being around 70-
95 μm.  The observed pore dimensions were considered to be appropriate to facilitate cellular 
migration and tissue ingrowth for possible in vivo applications [13].  The high degree of 
porosity and large pore size would seem ideal for enhanced vascularisation in vivo and possibly 
promote more rapid and direct osteogenesis formation from progenitor cells such as BMSCs.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. SEM micrographs of the macrostructure of the PLGA-coated bioactive glass-ceramic 
scaffold. 
 
Mechanical testing 
The bioactive glass-ceramic scaffolds demonstrated a mechanical response characteristic of 
open cell ceramic foams.  The response included an initial linear elastic region followed by a 
plateau section created through the brittle crushing of the struts, with final densification 
accompanying a stress increase. The compressive strength of the glass-ceramic scaffolds was 
0.12±0.03 MPa. On the other hand, the compressive strength of the PLGA-coated bioceramic 
scaffolds was 0.25±0.05 MPa, which was much higher than that of the as sintered scaffolds and 
was within the range of cancellous bone (i.e. 0.2-4 MPa) [5]. The addition of the PLGA coating 
acted to enhance the structural integrity of the scaffold and therefore provided it with a 
significant increase in compressive strength as well as a smoother and more stable stress-strain 
curve.  The currently obtained compressive strength for the PLGA coated scaffolds does 
however lie toward the lower end of the defined scale and may, in its present form, be incapable 
of functioning appropriately as an implant for load bearing sites in synovial joints. High 
sintering temperatures would promote improved the mechanical properties, however the 
increased presence of the crystalline phase would limit the bioactivity of the scaffold somewhat. 
Additional slurry coating to increase the strut thickness would enhance the compressive strength, 
but care must be taken at the same time not to restrict the pore interconnectivity of the scaffold. 
In this study, no coupling agent was used to enhance the interfacial bonding strength between 
the PLGA coating and the glass-ceramic strut. Thus, improvement of the interfacial bonding 
will need to be done in the future.   
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Figure 2. Stress-strain curve for the PLGA-coated bioactive glass-ceramic scaffold. 
 
In vitro cell culture 
Cell culturing activities were performed on the PLGA coated bioactive glass-ceramic composite 
scaffold to assess whether it possessed sufficient biocompatibility. It was apparent through 
observations that BMSCs had a high affinity for the surface of the scaffold and that cell 
migration, attachment, and proliferation readily occurred.  After only 3 days in culture, cell 
attachment was evident on this scaffold type and while the original spindle characteristic of the 
cells was maintained, initial cross linking between cells appeared to take place.  For culture time 
of 5 days significant proliferation of cells was apparent characterised by cell penetration and 
migration into the internal regions of the scaffold.  The morphology of cells at day 5 
transitioned from the original spindle shape to a more flattened appearance suggesting a near 
complete attachment and integration of the cell with the scaffold.  An increase in cross liking 
between cells was also observed at this 5 day interval.  At 21 days proliferation was substantial 
and approaching confluence, with cells of a flattened morphology appearing to line the surface 
of the scaffold (Figure 3). Additional cells looked to cross link transversely from ridges and 
grooves of the scaffold at positions elevated above the material surface as well as progressing 
across the large marcopores of the scaffold.  The cells also seemed to actively migrate to, and 
cover, the cracks and defects present in the scaffold.  The observation of this phenomenon was 
encouraging as it could potentially act to improve the overall mechanical properties of the 
scaffold as well as allowing for the transition of load to repair tissue as the material continues to 
resorb and these defects become larger.   
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Figure 3. SEM micrographs with different magnifications (A and B) of BMSCs cultured 
onto the PLGA-coated bioactive glass-ceramic scaffold cultured at day 21. 
 
 
CONCLUSION 
This paper outlined the development and characterisation of a novel porous PLGA-coated 58S 
bioactive glass-ceramic scaffold for subchondral bone tissue engineering.  Structural 
characterisation, mechanical testing and preliminary in vitro cell culture work were conducted.  
Results suggested that the PLGA-coated bioactive glass-ceramic scaffolds possessed respectable 
pore interconnectivity, a high porosity of ~88%, and a pore size range of 220-500 μm. 
Complementary cell culture investigations showed that the PLGA-coated bioactive glass-
ceramic scaffolds could facilitate the proliferation of BMSCs derived from patients with 
osteoarthritis with near confluence achieved by 21 days in culture.  While the PLGA coating 
was able to increase the mechanical integrity of the sintered porous 58S glass-ceramic scaffolds, 
the limited mechanical strength of ~0.25 MPa suggests that iterative refinement of the 
fabrication protocol or an alternative method will be required to optimise the mechanical 
properties without significantly compromising the overall biological properties. 
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